Versatility of Anabolic Androgenic Steroid-Induced Hepatotoxicity.

Abstract

The modified derivatives of testosterone, termed as androgenic steroids are indicated in the management of hypogonadism, visceral obesity and metabolic disorders. Anabolic androgenic steroids (AASs) however are surreptitiously used by athletes and body builders for cosmetic purpose owing to their anabolic effects on muscle mass and strength. The unsurveilled use of AASs subjects these users to various side effects involving multiple systems such as the endocrine, genitourinary, hepatobiliary, central nervous, musculoskeletal and psychosocial system. The liver is a hormone-sensitive organ owing to abundance of androgen receptors and is vulnerable to a wide array of hepatotoxicity ranging from asymptomatic liver enzyme elevation to life-threatening subacute liver failure. The type of drug-induced liver injury (DILI) due to AASs can be hepatocellular injury, cholestasis, fatty liver disease, chronic vascular injury and neoplastic disease. Herein, we report three cases of AAS-related DILI associated with AAS abuse.

• Authors: Vaibhav Patil, Dinesh Jothimani, Kavya Harika, Abdul Rahman Hakeem, Deepti Sachan, Mukul Vij, Mohamed Rela
• Journal: Journal of clinical and experimental hepatology (J Clin Exp Hepatol) 2022 Jan-Feb Vol. 12 Issue 1 Pg. 216-221 ISSN: 0973-6883 [Print] India
• PMID: 35068803 (Publication Type: Case Reports)
• Copyright: © 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.